Share
Journal Information
Most often read
3480
Doping and sports endocrinology: anabolic-androgenic steroidsJ.A. García-Arnés, N. García-Casares
Rev Clin Esp. 2022;222:612-20
3480
Open access
3425
Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: A scoping review in relation to a clinical caseM. Buj, G. Morales-Varas, A. Pedrosa-Guerrero, E. Alonso-Ciria
Rev Clin Esp. 2022;222:374-6
3425
3116
Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological featuresA. García-Lledó, M. del Palacio-Salgado, C. Álvarez-Sanz, M.M. Pérez-Gil, Á. Cruz-Díaz
Rev Clin Esp. 2022;222:354-8
3116
2711
Real-life effect on the control of risk factors associated with initiation of the cardiovascular polypill created from equipotent drugsM. Portela-Romero, S. Cinza-Sanjurjo, P. Conde-Sabarís, M. Rodríguez-Mañero, P. Mazón-Ramos, D. Rey-Aldana, J.R. González-Juanateyc
Rev Clin Esp. 2022;222:131-7
2711
Open access
2587
Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in SpainP. Llàcer Iborra, J. Núñez Villota
Rev Clin Esp. 2022;222:299-300
2587
2525
Prognosis of acute heart failure based on clinical data of congestionB. Espinosa, P. Llorens, V. Gil, X. Rossello, J. Jacob, P. Herrero, F.J. Martín-Sánchez, A. Alquézar-Arbé, J. Masip, Ò. Miró
Rev Clin Esp. 2022;222:321-31
2525
Open access
2423
Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2J. Reina
Rev Clin Esp. 2022;222:91-2
2423
2381
A population-based survey of the prevalence and risk factors of chronic obstructive pulmonary disease in Shanxi Province, ChinaR. Wang, J. Xu, Y. Wang
Rev Clin Esp. 2022;222:218-28
2381
Open access
2369
Vericiguat in heart failure: From scientific evidence to clinical practiceJ.R. González-Juanatey, M. Anguita-Sánchez, A. Bayes-Genís, J. Comín-Colet, A. García-Quintana, A. Recio-Mayoral, J.L. Zamorano-Gómez, J.M. Cepeda-Rodrigo, L. Manzano
Rev Clin Esp. 2022;222:359-69
2369
Open access
2367
Persistent COVID-19 syndrome. A narrative reviewA. López-Sampalo, M.R. Bernal-López, R. Gómez-Huelgas
Rev Clin Esp. 2022;222:241-50
2367
2191
Recommendations for oral treatment for adult patients with type 1 Gaucher diseaseM.Á. Torralba-Cabeza, M. Morado-Arias, A. Pijierro-Amador, M.C. Fernández-Canal, J. Villarrubia-Espinosa
Rev Clin Esp. 2022;222:529-42
2191
Open access
2174
Prevalence and clinical characteristics of symptomatic diffuse interstitial lung disease in rheumatoid arthritis in a Spanish populationM.G. Bonilla Hernán, L. Gómez-Carrera, M. Fernández-Velilla Peña, R. Álvarez-Sala Walther, A. Balsa
Rev Clin Esp. 2022;222:281-7
2174
Open access
2018
Comprehensive management of risk factors in peripheral vascular disease. Expert consensusV. Barrios, P. Beato, C. Brotons, R. Campuzano, J.F. Merino-Torres, J.M. Mostaza, N. Plana, J.A. Rubio, M. Comellas
Rev Clin Esp. 2022;222:82-90
2018
Open access
1827
Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMIL. Almenar Bonet, Á. González-Franco
Rev Clin Esp. 2022;222:235-40
1827
Open access
1655
Executive summary clinical practice guideline of postmenopausal, glucocortcioid-induced and male osteoporosis (2022 update). Spanish Society for Bone and Mineral Metabolism Investigation (SEIOMM)J.A. Riancho, P. Peris, J. González-Macías, J.L. Pérez-Castrillón
Rev Clin Esp. 2022;222:432-9
1655
Open access
1337
Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in SpainA. Salinas-Botrán, J. Sanz-Cánovas, J. Pérez-Somarriba, L.M. Pérez-Belmonte, L. Cobos-Palacios, M. Rubio-Rivas, S. de-Cossío-Tejido, J.M. Ramos-Rincón, M. Méndez-Bailón, R. Gómez-Huelgas
Rev Clin Esp. 2022;222:255-65
1337
1232
Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document “Treatment of type 2 diabetes mellitus in the elderly”F. Gómez-Peralta, F.J. Carrasco-Sánchez, A. Pérez, J. Escalada, F. Álvarez-Guisasola, C. Miranda-Fernández-Santos, J.J. Mediavilla-Bravo, R. Gómez-Huelgas
Rev Clin Esp. 2022;222:496-9
1232
Open access
1215
CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC studyJ. Carriel, R. Muñoz-Jaramillo, O. Bolaños-Ladinez, F. Heredia-Villacreses, J. Menéndez-Sanchón, J. Martin-Delgado
Rev Clin Esp. 2022;222:37-41
1215
1113
Incretin-based therapy for glycemic control of hospitalized patients with type 2 diabetes: a systematic reviewA.E. Gracia-Ramos, M.P. Cruz-Domínguez, E.O. Madrigal-Santillán
Rev Clin Esp. 2022;222:180-9
1113
1096
Glucocorticoid therapy in patients with COVID-19 and concurrent heart failureC.S. Kow, D.S. Ramachandram, S.S. Hasan
Rev Clin Esp. 2022;222:309-10
1096
Special content about COVID-19
- Pulmonary embolism during SARS-CoV-2 pandemic: Clinical and radiological features
- Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: A scoping review in relation to a clinical case
- The evolution of SARS-CoV-2 variants and their clinical and healthcare implications
- Clinical characteristics and risk factors for mortality on admission in patients with heart failure hospitalized due to COVID-19 in Spain
Publish in
Revista Clínica Española
Free access articles
Rev Clin Esp. 2023;223:461-9
Rev Clin Esp. 2023;223:387-95
Rev Clin Esp. 2021;221:55-61
Revista Clínica Española (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.